These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31755788)

  • 1. Bilateral Drug-Induced Uveitis and Epiretinal Membrane during the Treatment of a Metastatic Cutaneous Melanoma.
    Mozo Cuadrado M; Tabuenca Del Barrio L; Compains Silva E
    Ocul Immunol Inflamm; 2021 Apr; 29(3):543-545. PubMed ID: 31755788
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular toxicity due to Trametinib and Dabrafenib.
    Sarny S; Neumayer M; Kofler J; El-Shabrawi Y
    BMC Ophthalmol; 2017 Aug; 17(1):146. PubMed ID: 28818062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal Steroid Treatment for Uveitis Associated with Dabrafenib and Trametinib for Metastatic Cutaneous Melanoma.
    Woltsche N; Kruger MA; Weger M; Wolf IH; Seidel G
    Ocul Immunol Inflamm; 2021 Jul; 29(5):845-847. PubMed ID: 31906779
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral Ischemic Retinal Vasculitis in Metastatic Cutaneous Melanoma Patient Treated with Dabrafenib and Trametinib: A Case Report.
    Niro A; Recchimurzo N; Sborgia A; Guida M; Alessio G
    Ocul Immunol Inflamm; 2018; 26(5):783-785. PubMed ID: 27973971
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatic hemorrhage as a consequence of rapid response to combined targeted therapy in metastatic melanoma.
    Flaherty DC; Hoffner BW; Lau BJ; Hamid O; Faries MB
    J Surg Oncol; 2015 Dec; 112(8):844-5. PubMed ID: 26503563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute heart failure as a result of granulomatous myocarditis: case report on a patient with metastatic melanoma treated with dabrafenib and trametinib.
    Winkler JK; Buder-Bakhaya K; Ellert E; Herpel E; Martens UM; Enk A; Hassel JC
    J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):e31-e32. PubMed ID: 28695986
    [No Abstract]   [Full Text] [Related]  

  • 7. Uveitis and serous retinal detachment secondary to systemic dabrafenib and trametinib.
    Rueda-Rueda T; Sánchez-Vicente JL; Moruno-Rodríguez A; Molina-Socola FE; Martínez-Borrego AC; López-Herrero F
    Arch Soc Esp Oftalmol (Engl Ed); 2018 Sep; 93(9):458-462. PubMed ID: 29580759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DRB1*04:05 in two cases of Vogt-Koyanagi-Harada disease-like uveitis developing from an advanced melanoma patient treated by sequential administration of nivolumab and dabrafenib/trametinib therapy.
    Fujimura T; Kambayashi Y; Tanita K; Sato Y; Hidaka T; Otsuka A; Tanaka H; Furudate S; Hashimoto A; Aiba S
    J Dermatol; 2018 Jun; 45(6):735-737. PubMed ID: 29488243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma.
    Dika E; Patrizi A; Ribero S; Fanti PA; Starace M; Melotti B; Sperandi F; Piraccini BM
    Eur J Dermatol; 2016 Jun; 26(3):232-9. PubMed ID: 27019511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
    Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
    Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uveitis and Papillitis in the Setting of Dabrafenib and Trametinib Therapy for Metastatic Melanoma: A Case Report.
    Lim J; Lomax AJ; McNeil C; Harrisberg B
    Ocul Immunol Inflamm; 2018; 26(4):628-631. PubMed ID: 27892777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Case Series of Cutaneous Adverse Effects Associated With Dabrafenib and Trametinib.
    Lacroix JP; Wang B
    J Cutan Med Surg; 2017; 21(1):54-59. PubMed ID: 27624900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe erythema exudative multiforme developing from advanced melanoma treated with dabrafenib and trametinib followed by nivolumab.
    Fujimura T; Kambayashi Y; Hidaka T; Tamabuchi E; Otake E; Tono H; Mizuashi M; Furudate S; Aiba S
    J Dermatol; 2018 Feb; 45(2):e35-e36. PubMed ID: 28983948
    [No Abstract]   [Full Text] [Related]  

  • 14. Vogt-Kayanagi-Harada-Like Uveitis Induced by Dabrafenib/Trametinib Therapy for Cutaneous Malignant Melanoma.
    Kaymak NZ; Kaplan AT
    Ophthalmic Surg Lasers Imaging Retina; 2023 Aug; 54(8):477-480. PubMed ID: 37535619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes in patients with resected, high-risk melanoma with BRAF
    Schadendorf D; Hauschild A; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Larkin J; Nyakas M; Dutriaux C; Haydon A; Robert C; Mortier L; Lesimple T; Plummer R; Schachter J; Dasgupta K; Manson S; Koruth R; Mookerjee B; Kefford R; Dummer R; Kirkwood JM; Long GV
    Lancet Oncol; 2019 May; 20(5):701-710. PubMed ID: 30928620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis following dabrafenib and trametinib for metastatic melanoma.
    Zaloum A; Falet JR; Elkrief A; Chalk C
    Neurology; 2020 Feb; 94(7):322-323. PubMed ID: 31888971
    [No Abstract]   [Full Text] [Related]  

  • 17. Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.
    Si L; Zhang X; Shin SJ; Fan Y; Lin CC; Kim TM; Dechaphunkul A; Maneechavakajorn J; Wong CS; Ilankumaran P; Lee DY; Gasal E; Li H; Guo J
    Eur J Cancer; 2020 Aug; 135():31-38. PubMed ID: 32534242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of intracranial hemorrhage caused by combined dabrafenib and trametinib therapy for metastatic melanoma.
    Lee le M; Feun L; Tan Y
    Am J Case Rep; 2014 Oct; 15():441-3. PubMed ID: 25305754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posterior reversible encephalopathy syndrome in a melanoma patient with dabrafenib and trametinib treatment following immunotherapy.
    Stefanou MI; Gepfner-Tuma I; Brendle C; Kowarik M; Meiwes A; Eigentler T; Müller A; Garbe C; Ziemann U; Tabatabai G; Forschner A
    J Dtsch Dermatol Ges; 2020 Feb; 18(2):136-139. PubMed ID: 31814289
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial.
    Grob JJ; Amonkar MM; Karaszewska B; Schachter J; Dummer R; Mackiewicz A; Stroyakovskiy D; Drucis K; Grange F; Chiarion-Sileni V; Rutkowski P; Lichinitser M; Levchenko E; Wolter P; Hauschild A; Long GV; Nathan P; Ribas A; Flaherty K; Sun P; Legos JJ; McDowell DO; Mookerjee B; Schadendorf D; Robert C
    Lancet Oncol; 2015 Oct; 16(13):1389-98. PubMed ID: 26433819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.